SWOG 1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT02154490
Cancer - Lung
Principal Investigator: Ding Wang, MD
CANCER, LUNG, LUNG CANCER, SQUAMOUS CELL, RECURRENT, STAGE 4
Accepting Participants